Kurs
+1,69%
Kurs
+1,69%
Open
138,10
High
140,60
Low
137,00
Close
138,30
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
38,3 MNOK
Likviditet
38,3 MNOK
Rel. mcap
2,52%
Antal aktier
276 164
Likviditet under dagen för detta pressmeddelande
Kalender
| Tid* | ||
| 2025-10-29 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-30 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-08 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-05-05 | N/A | Årsstämma |
| 2025-02-19 | 12:00 | Bokslutskommuniké 2024 |
| 2024-11-13 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-07 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-24 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2024-05-23 | - | Årsstämma |
| 2024-05-15 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-21 | - | Bokslutskommuniké 2023 |
| 2023-11-08 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-09 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-10 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-04 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2023-05-03 | - | Årsstämma |
| 2023-02-24 | - | Bokslutskommuniké 2022 |
| 2023-02-23 | - | Bokslutskommuniké 2022 |
| 2022-11-02 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-10 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-11 | - | Kvartalsrapport 2022-Q1 |
| 2022-04-29 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2022-04-28 | - | Årsstämma |
| 2022-02-23 | - | Bokslutskommuniké 2021 |
| 2021-11-17 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-11 | - | Kvartalsrapport 2021-Q2 |
| 2021-07-28 | - | Extra Bolagsstämma 2021 |
| 2021-05-21 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2021-05-20 | - | Årsstämma |
| 2021-05-19 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-03 | - | Bokslutskommuniké 2020 |
| 2020-11-10 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-18 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-11 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2020-06-10 | - | Årsstämma |
| 2020-05-07 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-30 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2020-02-27 | - | Bokslutskommuniké 2019 |
| 2019-11-07 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-07 | - | Kvartalsrapport 2019-Q2 |
| 2019-06-19 | - | Extra Bolagsstämma 2019 |
| 2019-05-14 | - | Kvartalsrapport 2019-Q1 |
| 2019-05-10 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2019-05-09 | - | Årsstämma |
| 2019-02-27 | - | Bokslutskommuniké 2018 |
| 2018-11-08 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-08 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-23 | - | Kvartalsrapport 2018-Q1 |
| 2018-05-11 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2018-05-09 | - | Årsstämma |
| 2018-02-27 | - | Bokslutskommuniké 2017 |
| 2017-11-08 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-23 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-23 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-28 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2017-04-27 | - | Årsstämma |
| 2017-02-15 | - | Bokslutskommuniké 2016 |
| 2016-11-15 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-23 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-10 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-29 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2016-04-28 | - | Årsstämma |
| 2016-02-11 | - | Bokslutskommuniké 2015 |
| 2015-10-29 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-13 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-06 | - | Kvartalsrapport 2015-Q1 |
| 2015-05-02 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2015-04-30 | - | Årsstämma |
| 2015-02-12 | - | Bokslutskommuniké 2014 |
| 2014-11-06 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-26 | - | Kvartalsrapport 2014-Q2 |
| 2014-05-28 | - | X-dag ordinarie utdelning PHO 0.00 NOK |
| 2014-05-27 | - | Årsstämma |
| 2014-05-07 | - | Kvartalsrapport 2014-Q1 |
| 2014-02-27 | - | Bokslutskommuniké 2013 |
| 2013-10-23 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-22 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-23 | - | X-dag ordinarie utdelning |
| 2013-05-22 | - | Årsstämma |
| 2013-04-25 | - | Kvartalsrapport 2013-Q1 |
| 2013-02-28 | - | Bokslutskommuniké 2012 |
| 2012-10-26 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-24 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-10 | - | Årsstämma |
| 2012-04-26 | - | Kvartalsrapport 2012-Q1 |
| 2012-02-16 | - | Bokslutskommuniké 2011 |
| 2011-10-26 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-18 | - | Kvartalsrapport 2011-Q2 |
| 2011-04-27 | - | Årsstämma |
| 2011-04-27 | - | Kvartalsrapport 2011-Q1 |
| 2011-02-17 | - | Bokslutskommuniké 2010 |
| 2010-10-27 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-19 | - | Kvartalsrapport 2010-Q2 |
| 2010-04-28 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-19 | - | Bokslutskommuniké 2009 |
| 2009-11-26 | - | X-dag bonusutdelning |
Beskrivning
| Land | Norge |
|---|---|
| Lista | OB Match |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2021-04-06 07:30:12
Press Release - Oslo, Norway, 6 April 2021, Photocure ASA (OSE: PHO), The
Bladder Cancer Company, announces that President and Chief Executive Officer,
Daniel Schneider and Chief Financial Officer, Erik Dahl are scheduled to present
corporate overviews at two upcoming Healthcare Conferences in April.
Presentation details are as follows:
Solebury Trout European Biotech Investor Day: on April 7, 2021, Photocure
presents at 7:30pm CET / 1:30pm ET followed by individual investor meetings.
This virtual conference sponsored by Goodwin, Solebury Trout, Deutsche Bank and
NASDAQ showcases European biotech & healthcare companies.
You can sign up for the webcast
here (https://showroom.troutaccess.com/app?iframe=1#/webcast/HQ97XB).
Needham Annual Healthcare Conference: on April 15, 2021, Photocure presents at
2:45pm CET / 8:45am ET followed by individual investor meetings. This 20[th]
annual conference is sponsored by the U.S. bank Needham & Company.
Access to the live event/webcast is available
here (https://wsw.com/webcast/needham107/pho.ol/2530528Photocure).
For further information, please contact:
Dan Schneider
President and CEO
Photocure ASA
Tel: + 1-609 759-6515
Email: ds@photocure.com
Erik Dahl
Chief Financial Officer
Tel: +47 450 55 000
Email: ed@photocure.no
David Moskowitz
Head of Investor Relations
Tel: +1 202 280 0888
Email: david.moskowitz@photocure.com
Media Enquiries:
Geir Bjørlo
Corporate Communications (Norway)
Tel: +47 91540000
Email: geir.bjorlo@corpcom.no
About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com, www.cysview.com